The burgeoning field ofinvestigations into novel anxiolytics is rapidly expanding, with novel research chemicals showing promising results in preclinical and clinical studies. These substances often exhibit distinct mechanisms of action compared to traditional anti-anxiety medications, offering potential improvements for patients struggling with an